New Jersey Drugmaker Draws FDA Warning for Adulteration

Drug Industry Daily
A A
The FDA warned sterile drug manufacturer PharmScript for adulterated products and insanitary conditions at its Somerset, New Jersey facility.

To View This Article:

Login

Subscribe To Drug Industry Daily